Health~Holland
Eureka Biotech Call
Last verified:
Details
| Funder | Health~Holland |
| Budget | €400k–€750k PPP subsidy per project (Dutch partners) |
| Deadline | 25 September 2026 |
| Consortium | Required — at least 2 independent Dutch partners (1 company + 1 research organisation) and at least 2 independent partners from a priority country (1 company + 1 research organisation) |
| Application | 2-stage: central EUREKA submission portal + national submission portal |
| TRL | 4-7 |
| Eligible countries | NL |
Eligibility & scope
Open to Dutch SMEs and Dutch research organisations (healthcare providers and foundations are NOT eligible). Focus on cell & gene therapies (CGT) and Organ-on-Chip (OoC) technologies. Industrial research and/or experimental development (TRL 4-7). Co-funding (in-kind and/or cash) required from all partners. Priority partner countries: Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland. PPP subsidy covers a percentage of eligible project costs for Dutch partners only.
More from Health~Holland
Science for Industry Call
Deadline: 22 Sept 2026€500k–€1.2M PPP subsidy per project (large enterprises: personnel costs only, up to €250k)Health~Holland Science for Industry Call 2026
Deadline: 22 Sept 2026€500,000-€1,200,000 PPPHealth~Holland Organ-on-Chip Call 2026
Deadline: 22 Sept 2026PPP subsidyEureka Biotech Call 2026
Deadline: 25 Sept 2026€400k–€750k per project (Dutch partners)SME Call 2027
Deadline: 30 Nov 2026
Browse Related
Could Eureka Biotech Call be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →